These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 10191934)

  • 1. [Corticoids and allergy].
    Delacourt C
    Arch Pediatr; 1999; 6 Suppl 1():105S-107S. PubMed ID: 10191934
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-inflammatory actions of glucocorticoids: molecular mechanisms.
    Barnes PJ
    Clin Sci (Lond); 1998 Jun; 94(6):557-72. PubMed ID: 9854452
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular mechanisms of corticosteroid actions.
    Adcock IM; Ito K
    Monaldi Arch Chest Dis; 2000 Jun; 55(3):256-66. PubMed ID: 10948677
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of glucocorticoids on gene transcription.
    Hayashi R; Wada H; Ito K; Adcock IM
    Eur J Pharmacol; 2004 Oct; 500(1-3):51-62. PubMed ID: 15464020
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Corticosteroids, eosinophils and bronchial epithelial cells: new insights into the resolution of inflammation in asthma.
    Walsh GM; Sexton DW; Blaylock MG
    J Endocrinol; 2003 Jul; 178(1):37-43. PubMed ID: 12844334
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Abnormal glucocorticoid receptor-activator protein 1 interaction in steroid-resistant asthma.
    Adcock IM; Lane SJ; Brown CR; Lee TH; Barnes PJ
    J Exp Med; 1995 Dec; 182(6):1951-8. PubMed ID: 7500041
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Negative cross-talk between RelA and the glucocorticoid receptor: a possible mechanism for the antiinflammatory action of glucocorticoids.
    Caldenhoven E; Liden J; Wissink S; Van de Stolpe A; Raaijmakers J; Koenderman L; Okret S; Gustafsson JA; Van der Saag PT
    Mol Endocrinol; 1995 Apr; 9(4):401-12. PubMed ID: 7659084
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Pharmacology of glucocorticoids and ENT pathology].
    Devillier P
    Presse Med; 2001 Dec 22-29; 30(39-40 Pt 2):59-69. PubMed ID: 11819915
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glucocorticoid-regulated transcription factors.
    Adcock IM
    Pulm Pharmacol Ther; 2001; 14(3):211-9. PubMed ID: 11448148
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glucocorticoid receptor signaling in a bronchial epithelial cell line.
    LeVan TD; Behr FD; Adkins KK; Miesfeld RL; Bloom JW
    Am J Physiol; 1997 May; 272(5 Pt 1):L838-43. PubMed ID: 9176246
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glucocorticoids: mechanisms of action and anti-inflammatory potential in asthma.
    van der Velden VH
    Mediators Inflamm; 1998; 7(4):229-37. PubMed ID: 9792333
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interactions of glucocorticoids and beta 2-agonists.
    Adcock IM; Stevens DA; Barnes PJ
    Eur Respir J; 1996 Jan; 9(1):160-8. PubMed ID: 8834349
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cross-talk between pro-inflammatory transcription factors and glucocorticoids.
    Adcock IM; Caramori G
    Immunol Cell Biol; 2001 Aug; 79(4):376-84. PubMed ID: 11488985
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glucocorticosteroids.
    Barnes PJ
    Handb Exp Pharmacol; 2017; 237():93-115. PubMed ID: 27796513
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of glucocorticosteroids on inflammatory cells relevant to their therapeutic applications in asthma.
    Schleimer RP
    Am Rev Respir Dis; 1990 Feb; 141(2 Pt 2):S59-69. PubMed ID: 2178515
    [No Abstract]   [Full Text] [Related]  

  • 16. Glucocorticoids reduce inflammation in cystic fibrosis bronchial epithelial cells.
    Rebeyrol C; Saint-Criq V; Guillot L; Riffault L; Corvol H; Chadelat K; Ray DW; Clement A; Tabary O; Le Rouzic P
    Cell Signal; 2012 May; 24(5):1093-9. PubMed ID: 22285804
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Suppression of granulocyte-macrophage colony-stimulating factor expression by glucocorticoids involves inhibition of enhancer function by the glucocorticoid receptor binding to composite NF-AT/activator protein-1 elements.
    Smith PJ; Cousins DJ; Jee YK; Staynov DZ; Lee TH; Lavender P
    J Immunol; 2001 Sep; 167(5):2502-10. PubMed ID: 11509589
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Overexpression of the human glucocorticoid receptor alpha and beta isoforms inhibits AP-1 and NF-kappaB activities hormone independently.
    Gougat C; Jaffuel D; Gagliardo R; Henriquet C; Bousquet J; Demoly P; Mathieu M
    J Mol Med (Berl); 2002 May; 80(5):309-18. PubMed ID: 12021843
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rhinovirus infection causes steroid resistance in airway epithelium through nuclear factor κB and c-Jun N-terminal kinase activation.
    Papi A; Contoli M; Adcock IM; Bellettato C; Padovani A; Casolari P; Stanciu LA; Barnes PJ; Johnston SL; Ito K; Caramori G
    J Allergy Clin Immunol; 2013 Nov; 132(5):1075-1085.e6. PubMed ID: 23871663
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glucocorticoid effects on NF-kappaB binding in the transcription of the ICAM-1 gene.
    Liden J; Rafter I; Truss M; Gustafsson JA; Okret S
    Biochem Biophys Res Commun; 2000 Jul; 273(3):1008-14. PubMed ID: 10891363
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.